Hematologic Malignancy
Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions
CI-CAN-00000281Explore in graph →
Hematologic9 evidence items
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000281Explore in graph →
Research activity
Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.
| Window | Period | Records (count) | Exact query | Computed | Source |
|---|---|---|---|---|---|
| All time | … → 2026-09-28 | 5 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) | 2026-09-28 | pubmed |
| Last 5 years | 2021-01-01 → 2026-12-31 | 5 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2021/01/01:2026/12/31[dp]) | 2026-09-28 | pubmed |
| Preceding 5-year window | 2020-09-28 → 2025-09-27 | 5 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2020/09/28:2025/09/27[dp]) |
Data updated 3 days agoSource updated unknownsource: pubmed E-utilities
Literature
Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.
| 2026-09-28 |
| pubmed |
| Last 12 months | 2025-09-28 → 2026-09-28 | 1 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2025/09/28:2026/09/28[dp]) | 2026-09-28 | pubmed |
| y2016 | 2016-01-01 → 2016-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2016/01/01:2016/12/31[dp]) | 2026-09-28 | pubmed |
| y2017 | 2017-01-01 → 2017-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2017/01/01:2017/12/31[dp]) | 2026-09-28 | pubmed |
| y2018 | 2018-01-01 → 2018-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2018/01/01:2018/12/31[dp]) | 2026-09-28 | pubmed |
| y2019 | 2019-01-01 → 2019-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2019/01/01:2019/12/31[dp]) | 2026-09-28 | pubmed |
| y2020 | 2020-01-01 → 2020-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2020/01/01:2020/12/31[dp]) | 2026-09-28 | pubmed |
| y2021 | 2021-01-01 → 2021-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2021/01/01:2021/12/31[dp]) | 2026-09-28 | pubmed |
| y2022 | 2022-01-01 → 2022-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2022/01/01:2022/12/31[dp]) | 2026-09-28 | pubmed |
| y2023 | 2023-01-01 → 2023-12-31 | 0 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2023/01/01:2023/12/31[dp]) | 2026-09-28 | pubmed |
| y2024 | 2024-01-01 → 2024-12-31 | 4 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2024/01/01:2024/12/31[dp]) | 2026-09-28 | pubmed |
| y2025 | 2025-01-01 → 2025-12-31 | 2 | ("Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions"[tiab] OR "M/LN-eo with Tyrosine Kinase Gene Fusions"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Defining Gene Rearrangements"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR1"[tiab] OR "Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA, PDGFRB, And FGFR1"[tiab] OR "Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab] OR "Myeloid and Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2"[tiab]) AND (2025/01/01:2025/12/31[dp]) | 2026-09-28 | pubmed |
· Br J Haematol · 2014 · PMID 24456122 · validated civic_curation pubmed
· Blood Cancer J · 2015 · PMID 25658984 · validated civic_curation pubmed
· Leukemia · 2012 · PMID 21818111 · validated civic_curation pubmed
· Exp Hematol · 2014 · PMID 24407160 · validated civic_curation pubmed